South & Central America Glaucoma Therapeutics Market
Forecast to 2031 - Regional Analysis - by Drug Class (Beta Blockers, Alpha Adrenergic Agonists, Prostaglandins Analogues, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
No. of Pages: 126 | Report Code: BMIRE00031614 | Category: Pharmaceuticals
Middle East & Africa Glaucoma Therapeutics Market
Forecast to 2031 - Regional Analysis - by Drug Class (Beta Blockers, Alpha Adrenergic Agonists, Prostaglandins Analogues, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
No. of Pages: 136 | Report Code: BMIRE00031613 | Category: Pharmaceuticals
Asia Pacific Glaucoma Therapeutics Market
Forecast to 2031 - Regional Analysis - by Drug Class (Beta Blockers, Alpha Adrenergic Agonists, Prostaglandins Analogues, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
No. of Pages: 137 | Report Code: BMIRE00031612 | Category: Pharmaceuticals
Europe Glaucoma Therapeutics Market
Forecast to 2031 - Regional Analysis - by Drug Class (Beta Blockers, Alpha Adrenergic Agonists, Prostaglandins Analogues, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
No. of Pages: 133 | Report Code: BMIRE00031611 | Category: Pharmaceuticals
North America Glaucoma Therapeutics Market
Forecast to 2031 - Regional Analysis - by Drug Class (Beta Blockers, Alpha Adrenergic Agonists, Prostaglandins Analogues, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
No. of Pages: 132 | Report Code: BMIRE00031610 | Category: Pharmaceuticals
South & Central America Biologics Market
Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
No. of Pages: 147 | Report Code: BMIRE00031592 | Category: Pharmaceuticals
Middle East & Africa Biologics Market
Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
No. of Pages: 153 | Report Code: BMIRE00031591 | Category: Pharmaceuticals
Asia Pacific Biologics Market
Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
No. of Pages: 163 | Report Code: BMIRE00031590 | Category: Pharmaceuticals
Europe Biologics Market
Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
No. of Pages: 162 | Report Code: BMIRE00031589 | Category: Pharmaceuticals
North America Biologics Market
Forecast to 2031 - Regional Analysis - by Product (Monoclonal Antibodies, Vaccine, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectious Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), and Manufacturing (Outsourced and In-house)
No. of Pages: 146 | Report Code: BMIRE00031588 | Category: Pharmaceuticals
